Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    NCX 470

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nicox Announces Positive Feedback From Pre-NDA Meeting With FDA
    Nicox Announces Positive Feedback From Pre-NDA Meeting With FDA

    16 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/16/3238530/0/en/Nicox-Announces-Positive-Feedback-from-pre-NDA-Meeting-with-U-S-FDA-for-NCX-470.html

    GLOBENEWSWIRE
    16 Feb 2026
    Share Share
    Nicox to Present NCX 470 Phase 3 Data at AGS 2026 Meeting
    Nicox to Present NCX 470 Phase 3 Data at AGS 2026 Meeting

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235013/0/en/Nicox-to-Present-Data-from-NCX-470-Phase-3-Studies-at-American-Glaucoma-Society-AGS-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Nicox Announces H1 2026 Conferences and Data Presentations
    Nicox Announces H1 2026 Conferences and Data Presentations

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221299/0/en/Nicox-Announces-Conference-Attendance-in-H1-2026-and-Upcoming-Scientific-Data-Presentations.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Nicox Wraps Up NCX 470 NDA Data Generation For H1 2026 Submission
    Nicox Wraps Up NCX 470 NDA Data Generation For H1 2026 Submission

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3205951/0/en/Nicox-Completes-NCX-470-New-Drug-Application-Key-Data-Generation-for-Submission-as-Planned-in-H1-2026.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Nicox’s NCX 470 Shows 12-Month Efficacy in Denali Trial
    Nicox’s NCX 470 Shows 12-Month Efficacy in Denali Trial

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160086/0/en/Nicox-s-NCX-470-Demonstrates-Sustained-Efficacy-through-12-Months-in-Denali-Clinical-Trial-with-no-new-Safety-Observations.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share
    Nicox to Repay Debts Fully with NCX 470 Global Licensing
    Nicox to Repay Debts Fully with NCX 470 Global Licensing

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144181/0/en/Nicox-Expects-to-Fully-Repay-Financial-Debts-with-NCX-470-De-Risked-and-Globally-Licensed.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.